
Total value of biopharma M&A deals worldwide from 2010 to 2019, by top companies
Between 2010 and 2019, AbbVie was involved in a number of merger and acquisition deals worldwide, with a total value of around 253 billion U.S. dollars. This statistic illustrates the total value of biopharma merger and acquisition (M&A) deals worldwide between 2010 and 2019, by select leading companies.